Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shimin Ye"'
Autor:
Kongzhen Hu, Junqi Li, Lijuan Wang, Yong Huang, Li Li, Shimin Ye, Yanjiang Han, Shun Huang, Hubing Wu, Jin Su, Ganghua Tang
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 12, Iss 2, Pp 867-875 (2022)
In recent years, fibroblast activation protein (FAP) has emerged as an attractive target for the diagnosis and radiotherapy of cancers using FAP-specific radioligands. Herein, we aimed to design a novel 18F-labeled FAP tracer ([18F]AlF-P-FAPI) for FA
Externí odkaz:
https://doaj.org/article/fdf3051df79a400cabab14ff117a7779
Autor:
Kongzhen Hu, Li Li, Yong Huang, Shimin Ye, Jiawei Zhong, Qingsong Yan, Yuhua Zhong, Lilan Fu, Pengju Feng, Hongsheng Li
Publikováno v:
Pharmaceuticals, Vol 15, Iss 3, p 383 (2022)
Due to tumor heterogeneity and complex tumor–stromal interactions in multicellular systems, the efficiency of monospecific tracers for tumor diagnosis and therapy is currently limited. In light of the evidence of prostate-specific membrane antigen
Externí odkaz:
https://doaj.org/article/26afba3e9e0849bfa792d37648a085e2
Autor:
Li Li, Ganghua Tang, Shimin Ye, Kongzhen Hu, Yong Huang, Shun Huang, Hubing Wu, Junqi Li, Jin Su, Lijuan Wang, Yanjiang Han
Publikováno v:
Acta Pharmaceutica Sinica B. 12:867-875
In recent years, fibroblast activation protein (FAP) has emerged as an attractive target for the diagnosis and radiotherapy of cancers using FAP-specific radioligands. Herein, we aimed to design a novel 18F-labeled FAP tracer ([18F]AlF-P-FAPI) for FA
Publikováno v:
Nuclear medicine communications. 43(3)
Approximately 5% of prostatic primary tumors and 15% of metastatic tumors were found to be prostate-specific membrane antigen (PSMA)-negative. Targeting gastrin-releasing peptide receptor (GRPR) has been shown to complement patients with PSMA-negativ
Autor:
Kongzhen, Hu, Junqi, Li, Lijuan, Wang, Yong, Huang, Li, Li, Shimin, Ye, Yanjiang, Han, Shun, Huang, Hubing, Wu, Jin, Su, Ganghua, Tang
Publikováno v:
Acta pharmaceutica Sinica. B. 12(2)
In recent years, fibroblast activation protein (FAP) has emerged as an attractive target for the diagnosis and radiotherapy of cancers using FAP-specific radioligands. Herein, we aimed to design a novel
Autor:
Kongzhen Hu, Junqi Li, Lijuan Wang, Yong Huang, Li Li, Shimin Ye, Yanjiang Han, Shun Huang, Hubing Wu, Jin Su, Ganghua Tang
Background The recent development of many different types of radiotracers that target the fibroblast activation protein (FAP) has been promising for tumor diagnosis. Here, we set out to develop 18F-labeled FAP tracers for cancer-associated fibroblast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03522c56866b2491ae5e28e2344cf207
https://doi.org/10.21203/rs.3.rs-265235/v1
https://doi.org/10.21203/rs.3.rs-265235/v1
Publikováno v:
European journal of medicinal chemistry. 221
Prostate-specific membrane antigen (PSMA) has become as an outstanding prostate cancer-related target for diagnostic imaging and targeted radiotherapy. Clinical studies on a few PSMA radiotracers are currently underway to determine their efficacy as